BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 33099473)

  • 21. The prevalence of the c-kit exon 10 variant, M541L, in aggressive fibromatosis does not differ from the general population.
    Grabellus F; Worm K; Sheu SY; Siffert W; Schmid KW; Bachmann HS
    J Clin Pathol; 2011 Nov; 64(11):1021-4. PubMed ID: 21757432
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic interactions between ANLN and KDR are prognostic for breast cancer survival.
    Dai X; Chen X; Hakizimana O; Mei Y
    Oncol Rep; 2019 Dec; 42(6):2255-2266. PubMed ID: 31578580
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vascular endothelial growth factor (VEGF) in astrocytic gliomas--a prognostic factor?
    Oehring RD; Miletic M; Valter MM; Pietsch T; Neumann J; Fimmers R; Schlegel U
    J Neurooncol; 1999; 45(2):117-25. PubMed ID: 10778727
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Granular cell astrocytoma: an aggressive IDH-wildtype diffuse glioma with molecular genetic features of primary glioblastoma.
    Vizcaino MA; Palsgrove DN; Yuan M; Giannini C; Cabrera-Aldana EE; Pallavajjala A; Burger PC; Rodriguez FJ
    Brain Pathol; 2019 Mar; 29(2):193-204. PubMed ID: 30222900
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glioblastomas harboring gene fusions detected by next-generation sequencing.
    Woo HY; Na K; Yoo J; Chang JH; Park YN; Shim HS; Kim SH
    Brain Tumor Pathol; 2020 Oct; 37(4):136-144. PubMed ID: 32761533
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Loss of the AP-2alpha transcription factor is associated with the grade of human gliomas.
    Heimberger AB; McGary EC; Suki D; Ruiz M; Wang H; Fuller GN; Bar-Eli M
    Clin Cancer Res; 2005 Jan; 11(1):267-72. PubMed ID: 15671555
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential expression of vascular endothelial growth factor A, its receptors VEGFR-1, -2, and -3 and co-receptors neuropilin-1 and -2 does not predict bevacizumab response in human astrocytomas.
    Baumgarten P; Blank AE; Franz K; Hattingen E; Dunst M; Zeiner P; Hoffmann K; Bähr O; Mäder L; Goeppert B; Machein M; Seifert V; Steinbach JP; Plate KH; Harter PN; Mittelbronn M
    Neuro Oncol; 2016 Feb; 18(2):173-83. PubMed ID: 26627848
    [TBL] [Abstract][Full Text] [Related]  

  • 28. COX-2 and c-kit expression in canine gliomas.
    Jankovsky JM; Newkirk KM; Ilha MR; Newman SJ
    Vet Comp Oncol; 2013 Mar; 11(1):63-9. PubMed ID: 22235799
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of circulating tumor DNA from non-small cell lung cancer brain metastasis in cerebrospinal fluid samples.
    Ma C; Yang X; Xing W; Yu H; Si T; Guo Z
    Thorac Cancer; 2020 Mar; 11(3):588-593. PubMed ID: 31944608
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas.
    Hartmann C; Hentschel B; Wick W; Capper D; Felsberg J; Simon M; Westphal M; Schackert G; Meyermann R; Pietsch T; Reifenberger G; Weller M; Loeffler M; von Deimling A
    Acta Neuropathol; 2010 Dec; 120(6):707-18. PubMed ID: 21088844
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterisation of molecular alterations in microdissected archival gliomas.
    Walker C; Joyce KA; Thompson-Hehir J; Davies MP; Gibbs FE; Halliwell N; Lloyd BH; Machell Y; Roebuck MM; Salisbury J; Sibson DR; Du Plessis D; Broome J; Rossi ML
    Acta Neuropathol; 2001 Apr; 101(4):321-33. PubMed ID: 11355303
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of activated epidermal growth factor receptors, Ras-guanosine triphosphate, and mitogen-activated protein kinase in human glioblastoma multiforme specimens.
    Feldkamp MM; Lala P; Lau N; Roncari L; Guha A
    Neurosurgery; 1999 Dec; 45(6):1442-53. PubMed ID: 10598712
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vascular endothelial growth factor expression and vascular density as prognostic markers of survival in patients with low-grade astrocytoma.
    Abdulrauf SI; Edvardsen K; Ho KL; Yang XY; Rock JP; Rosenblum ML
    J Neurosurg; 1998 Mar; 88(3):513-20. PubMed ID: 9488306
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IDH-mutated astrocytomas with 19q-loss constitute a subgroup that confers better prognosis.
    Otani R; Uzuka T; Higuchi F; Matsuda H; Nomura M; Tanaka S; Mukasa A; Ichimura K; Kim P; Ueki K
    Cancer Sci; 2018 Jul; 109(7):2327-2335. PubMed ID: 29752851
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeted next-generation sequencing panel (TruSight Tumor 170) in diffuse glioma: a single institutional experience of 135 cases.
    Na K; Kim HS; Shim HS; Chang JH; Kang SG; Kim SH
    J Neurooncol; 2019 May; 142(3):445-454. PubMed ID: 30710203
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic implications of microvessel morphometry in diffuse astrocytic neoplasms.
    Korkolopoulou P; Patsouris E; Kavantzas N; Konstantinidou AE; Christodoulou P; Thomas-Tsagli E; Pananikolaou A; Eftychiadis C; Pavlopoulos PM; Angelidakis D; Rologis D; Davaris P
    Neuropathol Appl Neurobiol; 2002 Feb; 28(1):57-66. PubMed ID: 11849564
    [TBL] [Abstract][Full Text] [Related]  

  • 37. VEGFA, FLT1, KDR and colorectal cancer: assessment of disease risk, tumor molecular phenotype, and survival.
    Slattery ML; Lundgreen A; Wolff RK
    Mol Carcinog; 2014 Feb; 53 Suppl 1():E140-50. PubMed ID: 23794399
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TP53 codon 72 polymorphism may predict early tumour progression in paediatric pilocytic astrocytoma.
    Mascelli S; Nozza P; Jones DT; Colin C; Pistorio A; Milanaccio C; Ravegnani M; Consales A; Witt O; Morana G; Cama A; Capra V; Biassoni R; Pfister SM; Figarella-Branger D; Garrè ML; Raso A
    Oncotarget; 2016 Jul; 7(30):47918-47926. PubMed ID: 27374106
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutation profiling of anaplastic ependymoma grade III by Ion Proton next generation DNA sequencing.
    Butt E; Alyami S; Nageeti T; Saeed M; AlQuthami K; Bouazzaoui A; Athar M; Abduljaleel Z; Al-Allaf F; Taher M
    F1000Res; 2019; 8():613. PubMed ID: 32612806
    [No Abstract]   [Full Text] [Related]  

  • 40. The rs17084733 variant in the
    Ravegnini G; Serrano C; Simeon V; Sammarini G; Nannini M; Roversi E; Urbini M; Ferrè F; Ricci R; Tarantino G; Pantaleo MA; Hrelia P; Angelini S
    Epigenetics; 2019 Jun; 14(6):545-557. PubMed ID: 30983504
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.